A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

The following is a summary of “Identification of hypertension subtypes using microRNA profiles and machine learning,” ...

In a study published today in the ExRNA journal, researchers from the Novosibirsk Institute of Chemical Biology and Fundamental Medicine have proved that pre-analytical variables, as blood plasma or ...

Regulus Therapeutics (RGLS) stock soars after positive Phase 1b trial data for the company's lead asset, farabursen against a ...

By integrating qRT-PCR with the SVM algorithm, this study introduces a novel technological approach for identifying gutter oil based on microRNA abundance, offering a powerful tool for ensuring ...

Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors has the potential to improve patient outcomes through ...

AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, developed to aid in lung cancer ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...

TransCode Therapeutics (RNAZ) announced that the first patient in Cohort 4 of its Phase I clinical trial has received their initial dose.